Amendment ID: S1899-2-R1

Redraft Amendment 2

Warning Label on Compounded Products

Messrs. Montigny and Joyce move to amend the amendment in section 6, in the second paragraph by adding the following 2 sentences:- “The label shall also notify prescribed users if the compounded preparation is not tested or approved by the federal Food and Drug Administration or if the compounded preparation does not meet federal Food and Drug Administration good manufacturing guidelines. In such instances, the label shall notify prescribed users to contact their prescribing health care professional if the prescribed user has any questions."